Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Yang

Showing results (31-40 of 156) with videos related to

Pageof 16
Sort By:
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Annals of Surgical Oncology|April 24, 2014
Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trialJoal D Beane, James C Yang, Donald White, et al.
Cancer|January 30, 2014
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiationJennifer Tseng, Deborah E Citrin, Meryl Waldman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Richard A Morgan, James C Yang, Mio Kitano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinomaDina M Elaraj, Donald E White, Seth M Steinberg, et al.
Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing CancersQiong J Wang, Zhiya Yu, Ken-Ichi Hanada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cellsTakashi Inozume, Ken-Ichi Hanada, Qiong J Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumorQiong J Wang, Ken-ichi Hanada, Donna Perry-Lalley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigenHung T Khong, James C Yang, Suzanne L Topalian, et al.
Pageof 16

Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Annals of Surgical Oncology|April 24, 2014
Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trialJoal D Beane, James C Yang, Donald White, et al.
Cancer|January 30, 2014
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiationJennifer Tseng, Deborah E Citrin, Meryl Waldman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Richard A Morgan, James C Yang, Mio Kitano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinomaDina M Elaraj, Donald E White, Seth M Steinberg, et al.
Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing CancersQiong J Wang, Zhiya Yu, Ken-Ichi Hanada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cellsTakashi Inozume, Ken-Ichi Hanada, Qiong J Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumorQiong J Wang, Ken-ichi Hanada, Donna Perry-Lalley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigenHung T Khong, James C Yang, Suzanne L Topalian, et al.
Pageof 16